Botswana vs Congo: Cause of death, by non-communicable diseases, ages 15-59
Botswana
21.6%
in 2021
Congo
25.9%
in 2021
Botswana rank
185th
Congo rank
182nd
Cause of death, by non-communicable diseases, ages 15-59 over time
- Botswana
- Congo
How they compare
Congo currently reports 25.9% against 21.6% in Botswana, a difference of 4.3%.
That makes Congo's figure about 1.2 times Botswana's.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Congo ahead.
Botswana ranks 185th and Congo ranks 182nd of 185 countries.
Congo has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Botswana | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.8% | 28.2% | 19.3% | Congo |
| 2010s | 25.0% | 27.6% | 2.6% | Congo |
| 2020s | 24.9% | 26.2% | 1.3% | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Botswana or Congo?
- Congo, at 25.9% against 21.6% in Botswana as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Botswana and Congo?
- 4.3%, with Congo ahead.
- How many years of comparable data are there for Botswana and Congo?
- 6 years are reported by both, from 2000 to 2021.
- How do Botswana and Congo rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Botswana ranks 185th and Congo ranks 182nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.